Symptom Information: Sort according to HPO 

1
(HPO:0001250) Seizures Frequent [Orphanet] 1245 / 7739
2
(HPO:0002121) Absence seizures 62 / 7739
3
(HPO:0002133) Status epilepticus 59 / 7739
4
(HPO:0001992) Organic aciduria Very frequent [Orphanet] 28 / 7739
5
(HPO:0001252) Muscular hypotonia Very frequent [Orphanet] 990 / 7739
6
(HPO:0001324) Muscle weakness 859 / 7739
7
(HPO:0001251) Ataxia 413 / 7739
8
(HPO:0002066) Gait ataxia Very frequent [Orphanet] 327 / 7739
9
(HPO:0000708) Behavioral abnormality Frequent [Orphanet] 212 / 7739
10
(HPO:0001249) Intellectual disability 1089 / 7739
11
(HPO:0001263) Global developmental delay 853 / 7739
12
(HPO:0001270) Motor delay 322 / 7739
13
(HPO:0000496) Abnormality of eye movement 79 / 7739
14
(HPO:0000709) Psychosis 61 / 7739
15
(HPO:0000717) Autism 108 / 7739
16
(HPO:0000718) Aggressive behavior 109 / 7739
17
(HPO:0100716) Self-injurious behavior 43 / 7739
18
(HPO:0000738) Hallucinations 60 / 7739
19
(HPO:0000739) Anxiety 67 / 7739
20
(HPO:0000750) Delayed speech and language development 197 / 7739
21
(HPO:0000752) Hyperactivity 140 / 7739
22
(HPO:0001265) Hyporeflexia 208 / 7739
23
(HPO:0001939) Abnormality of metabolism/homeostasis 328 / 7739
24
(HPO:0002069) Generalized tonic-clonic seizures 96 / 7739
25
(HPO:0002123) Generalized myoclonic seizures 62 / 7739
26
(HPO:0002353) EEG abnormality 188 / 7739
27
(HPO:0002487) Hyperkinesis 7 / 7739
28
(OMIM) Delayed development, ranging from mild to severe 1 / 7739
29
(OMIM) Approximately 30% of patients show normal early development 1 / 7739
30
(HPO:0008947) Infantile muscular hypotonia 482 / 7739
31
(HPO:0010547) Muscle flaccidity 466 / 7739
32
(OMIM) MRI shows increased T2-weighted signals in the globus pallidi 1 / 7739
33
(OMIM) Autism, mild 1 / 7739
34
(OMIM) Psychosis in older patients 1 / 7739
35
(OMIM) Increased urinary excretion of 4-hydroxybutyric acid (GHB) 1 / 7739
36
(OMIM) Increased CSF and plasma GHB 1 / 7739
37
(OMIM) Increased urinary excretion of gamma-aminobutyric acid (GABA) 1 / 7739
38
(OMIM) Increased CSF and plasma GABA 1 / 7739
39
(OMIM) Decreased activity of succinic semialdehyde dehydrogenase (SSADH, ALDH5A1), less than 5% of control values 1 / 7739
40
(HPO:0012758) Neurodevelopmental delay Very frequent [Orphanet] 949 / 7739
41
(HPO:0000007) Autosomal recessive inheritance 2538 / 7739
42
(HPO:0003593) Infantile onset 249 / 7739
43
(HPO:0003812) Phenotypic variability 129 / 7739